Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4435659
Max Phase: Preclinical
Molecular Formula: C59H99N7O39
Molecular Weight: 1530.45
Molecule Type: Unknown
Associated Items:
ID: ALA4435659
Max Phase: Preclinical
Molecular Formula: C59H99N7O39
Molecular Weight: 1530.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H](OCCCCCCN=[N+]=[N-])O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@@H](O[C@@H]6O[C@H](CO[C@]7(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O7)[C@H](O)[C@H](O)[C@H]6O)[C@H]5NC(C)=O)[C@H]4O)[C@H]3NC(C)=O)[C@H]2O)[C@@H]1O
Standard InChI: InChI=1S/C59H99N7O39/c1-19(73)62-31-23(77)11-59(58(90)91,105-49(31)35(79)24(78)12-67)93-18-30-36(80)42(86)43(87)55(99-30)101-47-33(64-21(3)75)53(94-25(13-68)37(47)81)104-51-40(84)28(16-71)97-57(45(51)89)102-48-34(65-22(4)76)54(95-26(14-69)38(48)82)103-50-39(83)27(15-70)96-56(44(50)88)100-46-29(17-72)98-52(32(41(46)85)63-20(2)74)92-10-8-6-5-7-9-61-66-60/h23-57,67-72,77-89H,5-18H2,1-4H3,(H,62,73)(H,63,74)(H,64,75)(H,65,76)(H,90,91)/t23-,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36-,37+,38+,39-,40-,41+,42-,43+,44+,45+,46+,47-,48-,49+,50-,51-,52+,53-,54-,55-,56-,57-,59+/m0/s1
Standard InChI Key: BIQZTPFQBGGNJE-PTVQMFPESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1530.45 | Molecular Weight (Monoisotopic): 1529.5979 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC.. (2019) Expedient assembly of Oligo-LacNAcs by a sugar nucleotide regeneration system: Finding the role of tandem LacNAc and sialic acid position towards siglec binding., 180 [PMID:31351394] [10.1016/j.ejmech.2019.07.046] |
Source(1):